Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-08-11
1990-12-18
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142302, 514254, A61K 31495
Patent
active
049786610
ABSTRACT:
The present invention relates to the use of 6-halo-4-quinolone derivatives and pharmaceutical compositions comprising them as active ingredient, for the preparation of a medicament for the therapeutical application in rheumatoid arthritis.
Quinolone derivatives can be intra-articularly administered and act on different points of the pathological process of rheumathoid arthritis without local and general toxicity.
REFERENCES:
patent: 4772605 (1988-09-01), Naik et al.
Bayer et al., The Journal of Infectious Diseases, vol. 152, No. 4 (Oct. 1985), pp. 811-816.
Prere, et al., Chemical Abstracts, 105:75803j (1986).
The Merck Index, 11th ed., 1989, Merck and Co., Inc., Rahway, N.J. pp. 360, 1118.
Datlow Philip
Shah Mukund J.
LandOfFree
Use of 6-halo-4-quinolone compounds and pharmaceutical compositi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 6-halo-4-quinolone compounds and pharmaceutical compositi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 6-halo-4-quinolone compounds and pharmaceutical compositi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1425753